SF Healthcare Week: Vera Therapeutics’ announced this week that the FDA accepted the company’s filing for atacicept, a potential new treatment for IgA Nephropathy
BiotechTV - News
00:00
Dosing, Delivery, and Patient Acceptance
Marshall explains weekly dosing, auto-injector profile, and high self-administration rates from Phase II.
Play episode from 08:20
Transcript
